Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spina Bifida to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spina Bifida to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Spina Bifida Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 37
Abbreviations 37
Definitions 37
Research Methodology 38
Secondary Research 38
About GlobalData 39
Contact Us 39
Disclaimer 39
Source 39

List of Tables
Spina Bifida Therapeutics, Global, Clinical Trials by Region, 2018* 6
Spina Bifida Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Spina Bifida Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Spina Bifida Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Spina Bifida Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Spina Bifida Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Spina Bifida Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
Spina Bifida Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Spina Bifida to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Spina Bifida Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Spina Bifida Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Spina Bifida to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Spina Bifida Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Spina Bifida Therapeutics, Global, Clinical Trials by Phase, 2018* 20
Spina Bifida Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 21
Spina Bifida Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
Spina Bifida Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
Spina Bifida Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 24
Spina Bifida Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Spina Bifida Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Spina Bifida Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27

List of Figures
Spina Bifida Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Spina Bifida Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Spina Bifida Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Spina Bifida Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Spina Bifida Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Spina Bifida Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Spina Bifida Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
Spina Bifida Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14
Proportion of Spina Bifida to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Spina Bifida Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Spina Bifida Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Spina Bifida to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Spina Bifida Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Spina Bifida Therapeutics, Global, Clinical Trials by Phase (%), 2018* 20
Spina Bifida Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 21
Spina Bifida Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
Spina Bifida Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
Spina Bifida Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 24
Spina Bifida Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Spina Bifida Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Spina Bifida Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27
GlobalData Methodology 38

Companies Mentioned
- Sparks
- GlaxoSmithKline Plc
- C. H. Boehringer Sohn AG & Co KG